Who Should Get What for Upfront Therapy for Mantle Cell Lymphoma? скачать в хорошем качестве

Who Should Get What for Upfront Therapy for Mantle Cell Lymphoma?

For the past fifteen years, Lymphoma & Myeloma has been the premier forum on the latest advances in lymphoma, myeloma, and other plasma cell neoplasms. Over forty internationally recognized leaders in molecular biology, pathology, immunology, translational and clinical research have been involved to provide expertise and guidance on recent developments in the basic science, translational medicine and clinical trials. This Congress features an interdisciplinary approach, special lectures, debates and interactive techniques to explore the controversial, the upcoming, and the exciting in myeloma, Waldenstrom’s macroglobulinemia, chronic lymphocytic leukemia, lymphoma and Hodgkin’s disease. In this presentation, Dr. Kami Maddocks discusses who should get what for upfront therapy of mantle cell lymphoma (MCL). A continuing education program is offered as a supplement to this webcast at the following location: http://elc.imedex.com/ELC/Activity-Se... © 2015 Imedex, LLC.